Elanco Animal Health (ELAN) Other financing activities (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Other financing activities data on file, last reported at -$15.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities fell 114.29% year-over-year to -$15.0 million; the trailing twelve-month figure through Mar 2026 stood at -$10.0 million (changed 0.0% YoY), and the FY2025 full-year result was -$2.0 million, up 88.24% from the prior year.
• Other financing activities grew to -$15.0 million in Q1 2026, from -$17.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $35.0 million in Q3 2025 to a low of -$17.0 million in Q4 2025.
• A 5-year average of -$4.5 million and a median of -$7.0 million in 2023 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 537.5% in 2025, while the deepest fall reached 1200.0% in 2025.
• Tracing ELAN's Other financing activities over 5 years: stood at $1.0 million in 2022, then tumbled by 200.0% to -$1.0 million in 2023, then jumped by 700.0% to $6.0 million in 2024, then plunged by 383.33% to -$17.0 million in 2025, then gained by 11.76% to -$15.0 million in 2026.
• Business Quant data shows ELAN's Other financing activities at -$15.0 million in Q1 2026, -$17.0 million in Q4 2025, and $35.0 million in Q3 2025.